NCT00357084
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +100 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Paraproteinemias
Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.
3,004 public trials
571 recruiting studies
Paraproteinemias trial results
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +136 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00003289
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
- Locations
-
- Johns Hopkins Oncology Center Baltimore, Maryland, United States
NCT00083460
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
NCT00083538
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
NCT00083408
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
Completed
Anti-Angiogenesis Therapy Using Thalidomide in Patients With Waldenstrom's Macroglobulinemia
NCT00083707
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
NCT00081757
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
Completed
Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
NCT00093028
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States
NCT00083577
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States